QuidelOrtho

Q2 FY2026 EarningsQ2 FY26 results were mixed with a top-line beat but a significant bottom-line miss and a sharp downward revision to full-year guidance. Revenue of $630.9M (+3% YoY) exceeded the $618.8M consensus, driven by a 16% surge in Point of Care. However, adjusted EPS of $0.13 significantly missed the $0.04 loss expected by analysts due to higher-than-anticipated operating expenses and interest costs. Management drastically cut FY26 revenue and EPS guidance and withdrew free cash flow targets, citing VBP pricing headwinds in China and softer global respiratory demand.